Breast Cancer Therapeutics Market By Product, Regional Outlook, Technology Development, Competitive Landscape & Forecast, 2019 – 2025
The Breast Cancer Therapeutics Market is set to exceed USD 30,637.7 million by 2025; according to a new research study published by Global Market Insights, Inc. Rising prevalence of breast cancer launch of numerous diagnostic and screening programs globally and favorable insurance and reimbursement policies will serve as high influential factors for the global market growth.
Advancement in technologies for cancer biology, increasing research and development for introduction of novel drugs to treat the disease will stimulate industry growth over the coming years. Rising adoption of minimally invasive cancer therapy methods should improve patient compliance.
Moreover, increasing awareness towards disease prevention, early screening and diagnosis will further propel the industry size. However, prohibitive cost associated with breast cancer therapeutics may restrain its adoption in emerging economies.
Compliance to therapy may reduce due to high maintenance treatment price.
Targeted drug therapy market is estimated to witness significant growth at 10.3% over the forecast period owing to factors such as their structure that is deliberately designed to interact with their target and search for specific molecular targets that are associated with cancer. Growing focus of much anticancer drug development on targeted therapies will drive the augmented demand for these products.
Hormone drugs market was valued around USD 3,292.4 million in the year 2018. Features such as affecting the activities of tissues and cells at numerous sites in the body, frequently reaching their targets through bloodstream will drive the segment growth.
Moreover, slowing or stopping the development of hormone-sensitive tumors by interfering with effects of hormones on breast cancer cells or by blocking the body’s capability to produce hormones will offer significant segment growth opportunity.
Distribution of breast cancer therapeutics through retail pharmacies is estimated grow at 9.7% over the projection period. The distribution of breast cancer therapeutics through retail pharmacies has become the most popular medium.
In 2018, retail pharmacies held the largest market share and will grow at considerable rate over the forecast timeframe owing to increased number of pharmacies in both developed and developing regions.
U.S. market accounted for largest business share in 2018 and is anticipated to grow substantially at 9.1% over the forecast period. Increases access to breast cancer screening, diagnosis and treatment services will be the chief growth rendering factor.
Moreover, increasing adoption of therapy drug by patients will fuel regional business growth. Rising incidence of disease due to increasing exposure to factors such as use of hormone replacement therapy (HRT), lifestyle related factors such as alcohol consumption, obesity and alteration in family size which stimulates the usage rate of therapeutics over the forecast period will propel the industry growth.
The expanding healthcare space is blazed with a plethora of innovations brought forth by renowned giants who are relentlessly attempting to effectuate merchandizing of novel drugs that prove to be extremely beneficial for the patients - a trend that has phenomenally triggered product developments in breast cancer therapeutics industry. As per a recent news snippet, researchers of Massachusetts Institute of Technology have unveiled an AI-based breast cancer therapeutic model that is claimed to detect breast cancer in a much more efficient and accurate manner.
Reportedly, scholars of MIT’s Computer Science and Artificial Intelligence Laboratory in collaboration with Massachusetts General Hospital in Boston have integrated machine learning in the new model design. Allegedly, this is one of the biggest scoops in breast cancer therapeutics market in recent times.
Speaking of product landscape of breast cancer therapeutics industry, target drug therapy market is forecast to record remarkable proceeds over the forthcoming years, subject to a plethora of driving factors - inclination toward specific actionable target oriented drugs, growing research on specific molecular targets linked with cancer, and increasing anticancer drug development on targeted therapies. Estimates depict, targeted drug therapy accounted for a major portion of breast cancer therapeutics industry share in 2016.
Hormone drugs segment is another product domain which of late, has been witnessing an increasing popularity. Endorsed with a number of beneficiary features such as affecting the activities of cells and tissues at different locations of the body and fast reaching at targets through bloodstream, breast cancer therapeutics market from hormone drugs is slated to carve a profitable roadmap in the coming seven years.
Worldwide, breast cancer therapeutics industry seems to be pretty much competitive with the involvement of renowned giants like Roche Diagnostics, Eli Lilly, Novartis, Eisai, Celgene, AstraZeneca, Pfizer, and Sanofi. Product differentiation is one of the major growth strategies adopted by the market players to sustain in the competitive scenario.
Ongoing advancements in clinical trials have led to the advent of novel therapeutic approaches that identify specific biological targets. Though as of now, only a fraction of the leading giants offers treatment for breast tumors, experts claim, breast cancer therapeutics market is certain to witness remarkable progression with regards to its product landscape in the coming years, characterized by the increasing participation of SMBs toward the development of outcome-based solutions.
Chapter 1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
18.104.22.168. Paid sources
22.214.171.124. Unpaid sources
Chapter 2. Executive Summary
2.1. Breast cancer therapeutics industry 3600 synopsis, 2014 - 2025 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Distribution channel trends
2.1.4. Regional trends
Chapter 3. Breast Cancer Therapeutics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025 (USD Million)
3.3. Industry impact factors
3.3.1. Growth drivers
126.96.36.199. Increasing breast cancer prevalence in the developed countries
188.8.131.52. Advancements in cancer biology
184.108.40.206. Launch of several diagnostic and screening programs worldwide
220.127.116.11. Favorable insurance and reimbursement policies
Browse Full Report at www.gminsights.com/industr…ics-market
TABLE 1. Breast cancer therapeutics industry 3600 synopsis, 2014 – 2025
TABLE 2. Global breast cancer therapeutics market, 2014 – 2025 (USD Million)
TABLE 3. Global breast cancer therapeutics market, by product, 2014-2025 (USD Million)
TABLE 4. Global breast cancer therapeutics market, by distribution channel, 2014-2025 (USD Million)
TABLE 5. Global breast cancer therapeutics market, by region, 2014-2025 (USD Million)
TABLE 6. Industry impact forces
TABLE 7. Breast cancer therapeutics pipeline overview
TABLE 8. Hormone drugs market, by region, 2014 - 2025, (USD Million)
TABLE 9. Chemotherapy drugs market, by region, 2014 - 2025, (USD Million)
TABLE 10. Targeted drug therapy market, by region, 2014 - 2025, (USD Million)
Related Report- Aquaculture Vaccines Market
Know more at www.marketwatch.com/press-r…2019-05-31
Category: Market Research Publishers and RetailersCompany about: Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.